 CAMBRIDGE, Mass., Nov. 09, 2022 GLOBE NEWSWIRE -- Beam Therapeutics Inc. Nasdaq: BEAM, a biotechnology company developing precision genetic medicines through base editing, today announced that management will participate in the following upcoming investor conferences: 